XML 28 R18.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue Disaggregation
 9 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by revenue source:

            
   Three Months Ended December 31,  Nine Months Ended December 31,
   2024  2023  2024  2023
Human Care  $3,052,000   $2,461,000   $8,886,000   $7,286,000 
Animal Care   376,000    621,000    1,176,000    1,688,000 
Service and Royalty   136,000    56,000    472,000    322,000 
   $3,564,000   $3,138,000   $10,534,000   $9,296,000 

 

The following table shows the Company’s revenues by geographic region:

            
   Three Months Ended December 31,  Nine Months Ended December 31,
   2024  2023  2024  2023
United States  $614,000   $868,000   $1,930,000   $2,214,000 
Europe   1,257,000    1,217,000    3,943,000    3,488,000 
Asia   579,000    522,000    1,832,000    1,730,000 
Latin America   829,000    368,000    2,174,000    1,165,000 
Rest of the World   285,000    163,000    655,000    699,000 
Total  $3,564,000   $3,138,000   $10,534,000   $9,296,000